Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Co. | 1.05% | 59.52 | 1.4% | $1509.69m | |
| JNJ | Johnson & Johnson | 0.17% | 139.62 | 0.7% | $875.22m | |
| PFE | Pfizer Inc. | -0.26% | 38.04 | 0.9% | $788.99m | |
| MRK | Merck & Co., Inc. | -0.09% | 88.60 | 0.7% | $686.26m | |
| ABBV | AbbVie, Inc. | -0.57% | 86.70 | 2.3% | $666.00m | |
| LLY | Eli Lilly & Co. | 0.87% | 119.70 | 1.1% | $351.70m | |
| NVS | Novartis AG | 0.06% | 91.61 | 0.2% | $147.56m | |
| AZN | AstraZeneca Plc | -1.24% | 47.60 | 1.2% | $142.60m | |
| RETA | Reata Pharmaceuticals, Inc. | -2.72% | 199.03 | 3.5% | $135.84m | |
| GSK | GlaxoSmithKline Plc | 0.18% | 45.15 | 0.2% | $125.43m | |
| KRTX | Karuna Therapeutics, Inc. | -6.16% | 65.35 | 0.0% | $96.71m | |
| NVO | Novo Nordisk A/S | -0.53% | 57.07 | 0.1% | $89.48m | |
| SNY | Sanofi | -0.84% | 46.22 | 0.2% | $74.33m | |
| ALLK | Allakos, Inc. | -10.88% | 122.74 | 0.0% | $51.02m | |
| CNST | Constellation Pharmaceuticals, Inc. | -6.94% | 42.81 | 0.0% | $42.71m |
Company Profile
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.